Is Metformin Used for Weight Loss? What the Evidence Shows

Metformin is sometimes used off-label for weight loss, especially in people with insulin resistance, prediabetes, PCOS, type 2 diabetes, or antipsychotic-associated weight gain. It is not FDA-approved as a weight-loss drug, and average weight loss is usually modest. A clinician can help decide whether metformin or another evidence-based option fits your health history.

Is metformin actually used for weight loss?

Metformin is used for weight loss in some clinical settings, but that use is off-label. It is better understood as a diabetes and insulin-resistance medication that may lead to modest weight loss in some people, not as a primary obesity drug.

FDA-approved use: type 2 diabetes, not weight loss

Metformin, sold under brand names such as Glucophage, Glucophage XR, Riomet, Fortamet, and Glumetza, is part of the biguanide drug class. The FDA-approved use is to help control blood glucose in adults and some children with type 2 diabetes, together with diet and exercise 1.

Metformin is not FDA-approved for weight loss. That matters because the label does not define metformin as an obesity treatment, and it does not give weight-loss dosing instructions for people without diabetes 1.

What off-label prescribing means

Off-label prescribing means a licensed clinician uses an FDA-approved medicine for a purpose, group, or condition not listed on the FDA label. This can be appropriate in medicine, but it requires an individualized risk-benefit decision.

For metformin and weight, the potential upside is usually gradual, modest weight change. The trade-offs include nausea, diarrhea, low vitamin B12 over time, kidney-function concerns, and rare lactic acidosis risk in people with certain medical problems 1, 8.

What are the quick facts about metformin and weight loss?

Metformin may help some people lose weight, but it is not a fast or high-average-loss medication. Most evidence points to gradual change over months to years, with stronger reasons to consider it when insulin resistance is part of the picture.

• Metformin lowers liver glucose production and improves insulin sensitivity, which can reduce high insulin signaling in some people 1.
• It may also affect appetite regulation, gut hormones, the gut microbiome, and lac-phe, a molecule linked to exercise-related appetite signaling in newer research 6.
• Weight loss is not guaranteed, and some people have no meaningful weight change.
• Common side effects are digestive, including nausea, diarrhea, gas, and abdominal discomfort 1.
• Long-term use can lower vitamin B12 levels, so monitoring may be appropriate 1, 8.

How much weight do people usually lose on metformin?

Metformin weight loss is usually modest. In large prevention research, metformin helped some people lose weight and keep part of it off, but the average effect was smaller than intensive lifestyle intervention at the start 2, 3.

What the Diabetes Prevention Program found

In the Diabetes Prevention Program, adults at high risk for type 2 diabetes were assigned to placebo, metformin 850 mg twice daily, or intensive lifestyle intervention. Over about 2.8 years, diabetes incidence fell by 31% with metformin and 58% with lifestyle intervention versus placebo 2.

Weight change was part of that story. The metformin group had moderate average weight loss, while the lifestyle group lost more weight early. Individual results varied, and the trial was designed to prevent diabetes, not to treat obesity as its main outcome 2. Digestive side effects were more common with metformin than placebo 2.

Why results are usually modest and gradual

Metformin does not mimic the fullness signals of GLP-1 obesity medications. Its main effects are on hepatic glucose production, insulin sensitivity, and related metabolic pathways 1.

That is why the weight effect often looks slower. Some people notice appetite or craving changes, but others mainly see better fasting glucose, hemoglobin A1c, or insulin markers without major weight change. Digestive side effects can also limit tolerability 1.

Can you lose 20 pounds on metformin?

Some individuals in studies lost larger amounts, but 20 pounds is not a typical expectation from metformin alone. A long-term follow-up of Diabetes Prevention Program participants found that sustained weight loss occurred in a subset of people taking metformin, but results varied widely 3.

If a person’s goal is larger weight loss, a clinician may discuss nutrition, resistance training, sleep, obesity medications, or other medical causes of weight gain. They should also review contraindications before any prescription, including kidney function and lactic acidosis risk factors 1.

How might metformin affect appetite, insulin, and weight?

Metformin works through several overlapping pathways. The best-established effects are lower liver glucose output and better insulin sensitivity; newer research also points to gut and appetite signals, including lac-phe 1, 6.

Lower liver glucose production

The liver releases glucose between meals and overnight. Metformin reduces hepatic glucose production, which can lower fasting glucose and hemoglobin A1c in type 2 diabetes 1.

For weight, this may matter because lower glucose and insulin demand can improve the metabolic environment for some people. Still, this mechanism does not guarantee fat loss, and metformin can cause nausea, diarrhea, and abdominal symptoms 1.

Improved insulin sensitivity

Insulin resistance means the body needs more insulin to move glucose into cells. Metformin can improve insulin sensitivity and lower insulin levels in some settings, which may support modest weight change in people with prediabetes, type 2 diabetes, PCOS, or metabolic syndrome 1, 4.

The safety trade-off is that metformin is not right for everyone. Clinicians often review kidney function, alcohol use, liver disease, heart failure history, and upcoming contrast imaging before prescribing 1.

Appetite and gut-signaling effects, including lac-phe research

Metformin also appears to act in the gut. Research has linked metformin to changes in bile acids, gut hormones, the gut microbiome, and appetite-related signals 6.

A 2024 study reported that metformin increased lac-phe, a molecule also raised by intense exercise and linked with lower food intake in animal models 6. This is promising biology, but it does not mean metformin works like an exercise replacement or that everyone will lose weight. Side effects and contraindications still matter 1.

Who is most likely to benefit from metformin-related weight loss?

Metformin seems most useful for weight when insulin resistance is part of the problem. The strongest fit is often people with prediabetes, type 2 diabetes, PCOS, metabolic syndrome, or medication-related weight gain, but the decision is still individual.

Prediabetes and insulin resistance

The Diabetes Prevention Program studied people at high risk for type 2 diabetes, including many with elevated fasting glucose and impaired glucose tolerance. Metformin reduced diabetes risk compared with placebo, with the largest relative benefit in some higher-risk groups, including people with higher BMI and younger adults 2.

For weight, this supports metformin as a possible tool for certain insulin-resistant patients, not a stand-alone weight-loss answer. Digestive intolerance and B12 deficiency risk should be part of the same conversation 1, 8.

PCOS

Polycystic ovary syndrome, or PCOS, is often linked with insulin resistance, irregular periods, acne, excess hair growth, and weight gain. A Cochrane review found that metformin can improve some metabolic and reproductive outcomes in PCOS, though weight effects vary and are not the same for everyone 4.

People with PCOS may also be trying to conceive, using hormonal medications, or managing irregular bleeding. That makes clinician guidance important, especially because stomach side effects and B12 deficiency can affect adherence 1, 8.

Type 2 diabetes

Metformin is a first-line medication in many type 2 diabetes care plans because it lowers glucose without usually causing weight gain 1, 10. Some people lose weight, especially when it helps reduce high insulin levels or replaces medicines that promote weight gain.

People with type 2 diabetes still need a full medication review. Kidney function, hemoglobin A1c, fasting glucose, cardiovascular risk, hypoglycemia risk with other drugs, and digestive tolerance can all shape the plan 1, 10.

Antipsychotic-associated weight gain

Some antipsychotic medicines can cause weight gain and insulin resistance. A 2016 meta-analysis found that metformin reduced antipsychotic-associated weight gain compared with placebo in people with schizophrenia or schizoaffective disorder 5.

This use should be coordinated with the clinician managing the psychiatric medication. Stopping or changing psychiatric medication without medical guidance can be dangerous, and metformin still carries digestive, B12, and kidney-related precautions 1, 5.

Can a non-diabetic take metformin for weight loss?

Metformin can be prescribed off-label to some people without diabetes, but it should not be self-started. A safe decision depends on medical history, labs, medications, pregnancy status, and kidney function.

Why this is an individualized medical decision

A clinician may consider metformin for a non-diabetic person when there is prediabetes, insulin resistance, PCOS, metabolic syndrome, gestational diabetes history, or medication-related weight gain. The goal should be clear: better metabolic risk, modest weight support, or diabetes prevention, not a guaranteed number on the scale 2, 4, 5.

The clinician also has to weigh downsides. Metformin can cause digestive side effects, lower B12 over time, and raise rare lactic acidosis risk in certain kidney, liver, alcohol-use, or acute illness settings 1, 8.

Labs and health history a clinician may review

• Hemoglobin A1c and fasting glucose, to look for prediabetes or type 2 diabetes 10.
• Kidney function, often estimated with eGFR, because metformin labeling includes kidney-related restrictions and precautions 1.
• Vitamin B12 level if there are symptoms, anemia, neuropathy, or long-term use concerns 8.
• Medication list, including insulin, sulfonylureas, antipsychotics, hormones, and drugs that affect kidney function 1.
• Pregnancy plans, gestational diabetes history, alcohol use, liver disease, heart failure history, and upcoming contrast imaging 1.

Why buying or taking metformin without a prescription is risky

Taking metformin without a prescription can lead to missed contraindications, unsafe use during acute illness, counterfeit or poor-quality medication, and no plan for lab monitoring. This is especially risky for people with kidney disease, heavy alcohol use, dehydration, or upcoming contrast imaging 1.

A licensed provider and a legitimate pharmacy protect you in ways that a no-prescription source cannot. That safety axis matters for any prescription medication, including metformin and weight-loss medicines.

Does metformin reduce belly fat?

Metformin may help some people with abdominal obesity when insulin resistance is present, but it does not spot-reduce belly fat. If weight changes happen, they usually occur across the body over months, not from one area only.

What metformin may do for abdominal obesity and insulin resistance

Abdominal obesity is closely linked with insulin resistance, prediabetes, type 2 diabetes, and metabolic syndrome. By lowering liver glucose output and improving insulin sensitivity, metformin may help the metabolic drivers that make central weight gain harder to manage for some people 1, 2.

That possible benefit must be balanced with side effects. Digestive symptoms are common, and B12 monitoring may be needed with long-term therapy 1, 8.

Why spot-reducing belly fat is not realistic

No medication can choose where the body loses fat first. Genetics, hormones, sleep, stress, menopause status, alcohol intake, resistance training, and total energy balance all affect abdominal fat.

If belly size changes quickly, or if abdominal swelling comes with pain, shortness of breath, vomiting, yellow skin, or new severe symptoms, that is not a weight-loss issue and should be medically evaluated.

Which is better for weight loss: metformin, Ozempic, Wegovy, semaglutide, or tirzepatide?

Metformin and GLP-1 medications have different roles. Metformin is approved for type 2 diabetes and may cause modest weight loss, while semaglutide and tirzepatide include FDA-approved obesity products in specific branded forms, with different side effects and contraindications 1, 7, 9.

Comparison table: metformin vs GLP-1 medications

Metformin vs Ozempic: different approvals and expected effects

Ozempic is semaglutide, a GLP-1 receptor agonist. It is FDA-approved for type 2 diabetes and certain cardiovascular and kidney-risk indications, not as a weight-loss drug 7.

Metformin works mainly by lowering liver glucose production and improving insulin sensitivity. Ozempic works through GLP-1 pathways that increase glucose-dependent insulin release, slow gastric emptying, and affect appetite signaling 1, 7. Both can cause digestive symptoms, but GLP-1 products also carry warnings about pancreatitis, gallbladder disease, and thyroid C-cell tumors 7.

Metformin vs Wegovy: diabetes drug vs FDA-approved obesity drug

Wegovy is semaglutide, a GLP-1 receptor agonist labeled for chronic weight management in eligible adults and adolescents, plus cardiovascular risk reduction in certain adults 9. The FDA-approved starting dose for Wegovy is 0.25 mg once weekly for the first 4 weeks, with gradual titration toward maintenance doses described in the label 9.

That label-based dose information is not an instruction to start Wegovy or semaglutide. GLP-1 therapy requires a clinician review because side effects and contraindications include nausea, vomiting, diarrhea, pancreatitis warnings, gallbladder disease, kidney injury risk during dehydration, and the thyroid C-cell tumor boxed warning 9.

Metformin vs tirzepatide: different mechanisms and clinical roles

Tirzepatide is a dual GIP/GLP-1 receptor agonist. Mounjaro is labeled for type 2 diabetes, while Zepbound is labeled for chronic weight management in eligible patients and for obstructive sleep apnea in certain adults with obesity 11, 12.

Metformin may be considered when insulin resistance is central. Tirzepatide more directly targets appetite and incretin pathways, but it also has gastrointestinal side effects, pancreatitis and gallbladder warnings, and a thyroid C-cell tumor boxed warning 11, 12.

What weight-loss medication options does Chia offer if metformin is not the right fit?

Chia does not currently offer metformin. For patients who are looking for prescription weight-management care, we offer an online, clinician-reviewed path to compounded GLP-1 treatment, including semaglutide injections and tirzepatide tablets or injections when clinically appropriate.

Chia does not currently offer metformin

Metformin is included here for education and comparison only. If you are already taking metformin or considering it, a licensed clinician should guide that decision and monitor safety.

Compounded semaglutide injections through Chia

Chia offers compounded semaglutide injections through state-licensed 503A compounding pharmacies. Plans currently start at $249/month, and microdosing plans are available when clinically appropriate.

Semaglutide is the active ingredient in several FDA-approved branded products, including Ozempic, Wegovy, and Rybelsus, but compounded semaglutide is not FDA-approved and is not the same as those brands. Outcomes data are not established for compounded formulations.

Compounded tirzepatide tablets or injections through Chia

Chia offers compounded tirzepatide tablets and injections. Tablet plans currently start at $249/month, injection plans currently start at $299/month, and microdosing plans are available when clinically appropriate.

Tirzepatide is the active ingredient in branded products such as Mounjaro and Zepbound, but compounded tirzepatide is not FDA-approved and is not the same as those brands. A provider still needs to review side effects, contraindications, and fit.

Microdosing plans at Chia when clinically appropriate

Some Chia patients are evaluated for microdosing plans for semaglutide or tirzepatide. That does not mean a lower-dose plan is right for everyone. Dosing is provider-guided and adjusted over time based on response, tolerability, goals, and safety.

How online evaluation, prescribing, and shipping work

Chia care is 100% online. You complete a short health questionnaire through the eligibility quiz, a licensed US provider reviews your history, and medication is prescribed only when clinically appropriate. If prescribed, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door.

Some patients may also explore Chia protocols such as Weight + Energy or Weight + Muscle. These are still prescription pathways, not automatic orders, and eligibility depends on medical history, BMI or other risk factors, medications, labs when needed, and clinician judgment.

What are the side effects and safety issues with metformin?

Metformin is widely used, but it is still a prescription medication with real safety issues. The most common side effects are digestive, while the most important rare risk is lactic acidosis in vulnerable situations 1.

Common digestive side effects

Common metformin side effects include diarrhea, nausea, vomiting, gas, indigestion, abdominal discomfort, and loss of appetite 1. Extended-release forms may be easier for some people to tolerate, but that is a clinician decision.

Digestive side effects can also cause dehydration if vomiting or diarrhea is severe. Dehydration can worsen kidney stress, which matters because kidney function is central to metformin safety 1.

Vitamin B12 deficiency with long-term use

Long-term metformin use has been linked with lower vitamin B12 levels. In the Diabetes Prevention Program Outcomes Study, metformin use was associated with biochemical B12 deficiency and anemia risk over time 8.

Low B12 can cause fatigue, numbness, tingling, balance problems, memory symptoms, and anemia. These symptoms can overlap with other conditions, so lab testing and clinician review matter 8.

Kidney function, lactic acidosis risk, and contrast imaging precautions

Metformin labeling includes a boxed warning for lactic acidosis, a rare but serious buildup of lactic acid 1. Risk rises in certain settings, including significant kidney impairment, dehydration, sepsis, hypoxia, heavy alcohol use, and some contrast-imaging situations 1.

This is one reason metformin should not be bought from no-prescription sources. A clinician can decide when to check kidney labs, pause medication during acute illness, or plan around imaging 1.

When to contact a clinician urgently

Urgent symptoms include severe weakness, unusual muscle pain, trouble breathing, severe sleepiness, feeling cold, slow or irregular heartbeat, severe vomiting or diarrhea, fainting, or signs of dehydration. These symptoms need prompt medical advice because they may signal a serious reaction or another urgent condition 1.

What should you ask a clinician before using metformin for weight loss?

Before using metformin for weight loss, ask whether the goal is metabolic health, diabetes prevention, PCOS support, or weight change. Also ask what labs, side effects, and monitoring plan make sense for you.

Eligibility and contraindications

• Do I have prediabetes, insulin resistance, PCOS, type 2 diabetes, metabolic syndrome, or another reason metformin is being considered?
• What are my hemoglobin A1c, fasting glucose, and kidney-function results?
• Do I have any kidney, liver, heart, alcohol-use, dehydration, or contrast-imaging risks that change the plan 1?
• Could metformin interact with my current medications or raise hypoglycemia risk when combined with diabetes drugs 1?
• Should vitamin B12 be checked now or later, especially if I use metformin long term 8?

Realistic goals and monitoring

A realistic metformin goal may be better fasting glucose, lower A1c, less progression toward diabetes, or modest weight support. The Diabetes Prevention Program showed diabetes-risk reduction, but not dramatic average weight loss 2.

Ask how success will be measured. Scale weight alone can miss changes in A1c, waist size, blood pressure, lipids, strength, and medication tolerability.

How lifestyle, sleep, and resistance training fit in

Lifestyle change had a larger early effect than metformin in the Diabetes Prevention Program 2. That does not mean lifestyle is easy or that medication is wrong. It means the strongest plan often combines nutrition, protein, resistance training, sleep, stress care, and medication when appropriate.

Resistance training is especially important during weight loss because it helps preserve muscle. That matters whether a person uses metformin, a GLP-1 medication, or no medication at all.

What are the key takeaways?

• Metformin is sometimes used off-label for weight loss, but its FDA-approved role is type 2 diabetes glucose control 1.
• Average weight loss with metformin is usually modest and gradual; stronger effects are more likely when insulin resistance, prediabetes, PCOS, type 2 diabetes, or antipsychotic-associated weight gain is part of the picture 2, 4, 5.
• Metformin’s main mechanisms include lower liver glucose production, improved insulin sensitivity, and gut-related appetite signaling 1, 6.
• Side effects and safety issues include nausea, diarrhea, vitamin B12 deficiency, kidney-function precautions, and rare lactic acidosis risk 1, 8.
• Chia does not currently offer metformin; if metformin is not the right fit, our providers can evaluate whether compounded semaglutide or compounded tirzepatide is clinically appropriate.

Keep reading

Weight Loss Medication

Metformin Dose for Weight Loss: What the Evidence Actually Shows

Weight Loss Medications

Metformin Dose for Weight Loss: What the Evidence Actually Shows

Weight Loss Medications

Metformin for Weight Loss: How It Works, How Much to Expect, and Who It’s For